Competitive Reverse-Transcriptase Polymerase Chain Reaction without an Artificial Internal Standard

M. E. Zenilman, W. Graham, K. Tanner, A. R. Shuldiner

Research output: Contribution to journalArticle

Abstract

Advances in our understanding of molecular and cellular physiology necessitate that mRNA levels for specific growth factors and other rare transcripts be measured quantitatively in small samples. Conventional methods such as Northern blot analysis and solution hybridization/ribonuclease protection are not sufficiently sensitive. We now report the theory, development, and validation of a rapid and highly sensitive assay, the RNA/DNA quantitative polymerase chain reaction (RD-PCR), which uses a competitive PCR approach to measure the number of copies of a specific mRNA per cell. Total nucleic acid (RNA and genomic DNA) is isolated from cells in culture. The mRNA of interest is first reverse-transcribed with an oligomer bearing a complementary sequence specific for the mRNA at its 3′-end, and a sequence complementary to an intron of the desired gene at the 5′-end. Competitive PCR is then performed in the presence of the cDNA product and endogenous genomic DNA, with an upstream primer complementary to the exon sequence of the gene of interest, and a downstream primer complementary to the intron sequence that was tagged to the cDNA. The cell′s own genomic DNA is thereby used as the internal standard. To control for the efficiency of reverse transcription, a standard curve is used in each assay. The technique was validated by comparing the quantitation of insulin-like growth factor I (IGF-I) mRNA in two human cell lines by RD-PCR and by RNase protection analysis. Both methods gave similar numbers of copies of IGF-I mRNA per cell. For accurate analysis, RNase protection required at least 107 cells; RD-PCR required as little as 102 cells. We conclude that RD-PCR is a rapid and highly sensitive method to quantitate low abundance mRNA from small numbers of cells and is especially versatile when quantitation is necessary in multiple samples.

Original languageEnglish (US)
Pages (from-to)339-346
Number of pages8
JournalAnalytical Biochemistry
Volume224
Issue number1
DOIs
StatePublished - Jan 1995

Fingerprint

Polymerase chain reaction
RNA-Directed DNA Polymerase
Reverse Transcriptase Polymerase Chain Reaction
Messenger RNA
DNA-Directed DNA Polymerase
Polymerase Chain Reaction
RNA
Ribonucleases
Insulin-Like Growth Factor I
Introns
Assays
DNA
Bearings (structural)
Complementary DNA
Genes
Physiology
Transcription
Oligomers
Northern Blotting
Nucleic Acids

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology
  • Biophysics
  • Biochemistry

Cite this

Competitive Reverse-Transcriptase Polymerase Chain Reaction without an Artificial Internal Standard. / Zenilman, M. E.; Graham, W.; Tanner, K.; Shuldiner, A. R.

In: Analytical Biochemistry, Vol. 224, No. 1, 01.1995, p. 339-346.

Research output: Contribution to journalArticle

Zenilman, M. E. ; Graham, W. ; Tanner, K. ; Shuldiner, A. R. / Competitive Reverse-Transcriptase Polymerase Chain Reaction without an Artificial Internal Standard. In: Analytical Biochemistry. 1995 ; Vol. 224, No. 1. pp. 339-346.
@article{0b1268debb1847009a26d037238b41d9,
title = "Competitive Reverse-Transcriptase Polymerase Chain Reaction without an Artificial Internal Standard",
abstract = "Advances in our understanding of molecular and cellular physiology necessitate that mRNA levels for specific growth factors and other rare transcripts be measured quantitatively in small samples. Conventional methods such as Northern blot analysis and solution hybridization/ribonuclease protection are not sufficiently sensitive. We now report the theory, development, and validation of a rapid and highly sensitive assay, the RNA/DNA quantitative polymerase chain reaction (RD-PCR), which uses a competitive PCR approach to measure the number of copies of a specific mRNA per cell. Total nucleic acid (RNA and genomic DNA) is isolated from cells in culture. The mRNA of interest is first reverse-transcribed with an oligomer bearing a complementary sequence specific for the mRNA at its 3′-end, and a sequence complementary to an intron of the desired gene at the 5′-end. Competitive PCR is then performed in the presence of the cDNA product and endogenous genomic DNA, with an upstream primer complementary to the exon sequence of the gene of interest, and a downstream primer complementary to the intron sequence that was tagged to the cDNA. The cell′s own genomic DNA is thereby used as the internal standard. To control for the efficiency of reverse transcription, a standard curve is used in each assay. The technique was validated by comparing the quantitation of insulin-like growth factor I (IGF-I) mRNA in two human cell lines by RD-PCR and by RNase protection analysis. Both methods gave similar numbers of copies of IGF-I mRNA per cell. For accurate analysis, RNase protection required at least 107 cells; RD-PCR required as little as 102 cells. We conclude that RD-PCR is a rapid and highly sensitive method to quantitate low abundance mRNA from small numbers of cells and is especially versatile when quantitation is necessary in multiple samples.",
author = "Zenilman, {M. E.} and W. Graham and K. Tanner and Shuldiner, {A. R.}",
year = "1995",
month = "1",
doi = "10.1006/abio.1995.1049",
language = "English (US)",
volume = "224",
pages = "339--346",
journal = "Analytical Biochemistry",
issn = "0003-2697",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Competitive Reverse-Transcriptase Polymerase Chain Reaction without an Artificial Internal Standard

AU - Zenilman, M. E.

AU - Graham, W.

AU - Tanner, K.

AU - Shuldiner, A. R.

PY - 1995/1

Y1 - 1995/1

N2 - Advances in our understanding of molecular and cellular physiology necessitate that mRNA levels for specific growth factors and other rare transcripts be measured quantitatively in small samples. Conventional methods such as Northern blot analysis and solution hybridization/ribonuclease protection are not sufficiently sensitive. We now report the theory, development, and validation of a rapid and highly sensitive assay, the RNA/DNA quantitative polymerase chain reaction (RD-PCR), which uses a competitive PCR approach to measure the number of copies of a specific mRNA per cell. Total nucleic acid (RNA and genomic DNA) is isolated from cells in culture. The mRNA of interest is first reverse-transcribed with an oligomer bearing a complementary sequence specific for the mRNA at its 3′-end, and a sequence complementary to an intron of the desired gene at the 5′-end. Competitive PCR is then performed in the presence of the cDNA product and endogenous genomic DNA, with an upstream primer complementary to the exon sequence of the gene of interest, and a downstream primer complementary to the intron sequence that was tagged to the cDNA. The cell′s own genomic DNA is thereby used as the internal standard. To control for the efficiency of reverse transcription, a standard curve is used in each assay. The technique was validated by comparing the quantitation of insulin-like growth factor I (IGF-I) mRNA in two human cell lines by RD-PCR and by RNase protection analysis. Both methods gave similar numbers of copies of IGF-I mRNA per cell. For accurate analysis, RNase protection required at least 107 cells; RD-PCR required as little as 102 cells. We conclude that RD-PCR is a rapid and highly sensitive method to quantitate low abundance mRNA from small numbers of cells and is especially versatile when quantitation is necessary in multiple samples.

AB - Advances in our understanding of molecular and cellular physiology necessitate that mRNA levels for specific growth factors and other rare transcripts be measured quantitatively in small samples. Conventional methods such as Northern blot analysis and solution hybridization/ribonuclease protection are not sufficiently sensitive. We now report the theory, development, and validation of a rapid and highly sensitive assay, the RNA/DNA quantitative polymerase chain reaction (RD-PCR), which uses a competitive PCR approach to measure the number of copies of a specific mRNA per cell. Total nucleic acid (RNA and genomic DNA) is isolated from cells in culture. The mRNA of interest is first reverse-transcribed with an oligomer bearing a complementary sequence specific for the mRNA at its 3′-end, and a sequence complementary to an intron of the desired gene at the 5′-end. Competitive PCR is then performed in the presence of the cDNA product and endogenous genomic DNA, with an upstream primer complementary to the exon sequence of the gene of interest, and a downstream primer complementary to the intron sequence that was tagged to the cDNA. The cell′s own genomic DNA is thereby used as the internal standard. To control for the efficiency of reverse transcription, a standard curve is used in each assay. The technique was validated by comparing the quantitation of insulin-like growth factor I (IGF-I) mRNA in two human cell lines by RD-PCR and by RNase protection analysis. Both methods gave similar numbers of copies of IGF-I mRNA per cell. For accurate analysis, RNase protection required at least 107 cells; RD-PCR required as little as 102 cells. We conclude that RD-PCR is a rapid and highly sensitive method to quantitate low abundance mRNA from small numbers of cells and is especially versatile when quantitation is necessary in multiple samples.

UR - http://www.scopus.com/inward/record.url?scp=0028831176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028831176&partnerID=8YFLogxK

U2 - 10.1006/abio.1995.1049

DO - 10.1006/abio.1995.1049

M3 - Article

C2 - 7535986

AN - SCOPUS:0028831176

VL - 224

SP - 339

EP - 346

JO - Analytical Biochemistry

JF - Analytical Biochemistry

SN - 0003-2697

IS - 1

ER -